E71.440
BillableRuvalcaba-Myhre-Smith syndrome
Ruvalcaba-Myhre-Smith syndrome
Coding Notes
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
- •transitory endocrine and metabolic disorders specific to newbornP70-P74
- •androgen insensitivity syndromeE34.5
- •congenital adrenal hyperplasiaE25.0
- •hemolytic anemias attributable to enzyme disordersD55
- •Marfan syndromeQ87.4
- •5-alpha-reductase deficiencyE29.1
- •Muscle carnitine palmitoyltransferase deficiencyE71.314
Related Codes(1)
Also Known As / Clinical Terms(69)
SNOMED CT
- Bannayan syndrome234138005
- Bannayan-Riley-Ruvalcaba syndrome234138005
- Bannayan-Zonana syndrome234138005
- Macrocephaly with multiple lipomas and haemangiomas234138005
- Macrocephaly with multiple lipomas and hemangiomas234138005
- Riley Smith syndrome234138005
- Ruvalcaba Myhre Smith syndrome234138005
- PTEN hamartoma tumor syndrome722859001
- PTEN hamartoma tumour syndrome722859001
UMLS
- BRRSC0265326
- BZSC0265326
- Bannayan Riley Ruvalcaba SyndromeC0265326
- Bannayan SyndromeC0265326
- Bannayan Zonana SyndromeC0265326
- Bannayan syndromeC0265326
- Bannayan syndrome (disorder)C0265326
- Bannayan-Riley-Ruvalcaba SyndromeC0265326
- Bannayan-Riley-Ruvalcaba syndromeC0265326
- Bannayan-Ruvalcaba-Riley SyndromeC0265326
- Bannayan-Ruvalcaba-Riley syndromeC0265326
- Bannayan-Zonana SyndromeC0265326
- Bannayan-Zonana syndromeC0265326
- Macrocephaly with Multiple Lipomas and HemangiomasC0265326
- Macrocephaly with multiple lipomas and haemangiomasC0265326
- Macrocephaly with multiple lipomas and hemangiomasC0265326
- Macrocephaly, Multiple Lipomas, and HemangiomataC0265326
- Macrocephaly, Pseudopapilledema, and Multiple HemangiomasC0265326
- Macrocephaly, Pseudopapilledema, and Multiple HemangiomataC0265326
- Myhre Riley Smith SyndromeC0265326
- Myhre-Riley-Smith SyndromeC0265326
- Myhre-Riley-Smith syndromeC0265326
- Riley Smith SyndromeC0265326
- Riley Smith syndromeC0265326
- Riley-Smith SyndromeC0265326
- Riley-Smith syndromeC0265326
- Ruvalcaba Myhre Smith SyndromeC0265326
- Ruvalcaba Myhre Smith syndromeC0265326
- Ruvalcaba-Myhre SyndromeC0265326
- Ruvalcaba-Myhre syndromeC0265326
- Ruvalcaba-Myhre-Smith SyndromeC0265326
- Ruvalcaba-Myhre-Smith syndromeC0265326
- bannayan syndromeC0265326
- bannayan zonana syndromeC0265326
- bannayan-zonana syndromeC0265326
- riley smith syndromeC0265326
- riley-smith syndromeC0265326
- ruvalcaba-myhre syndromeC0265326
Clinical Terms
- Bannayan-Ruvalcaba-Riley Syndrome
- PTEN hamartoma tumour syndrome
- Macrocephaly with Multiple Lipomas and Hemangiomas
- Bannayan syndrome (disorder)
- BZS
- Ruvalcaba Myhre Smith Syndrome
- Bannayan syndrome
- Macrocephaly, Multiple Lipomas, and Hemangiomata
- Riley Smith Syndrome
- riley-smith syndrome
- Macrocephaly, Pseudopapilledema, and Multiple Hemangiomata
- Ruvalcaba-Myhre Syndrome
- Bannayan Zonana Syndrome
- Myhre Riley Smith Syndrome
- Bannayan Riley Ruvalcaba Syndrome
- bannayan-zonana syndrome
- Macrocephaly, Pseudopapilledema, and Multiple Hemangiomas
- BRRS
- Myhre-Riley-Smith syndrome
- Macrocephaly with multiple lipomas and haemangiomas
- Bannayan-Riley-Ruvalcaba Syndrome
- PTEN hamartoma tumor syndrome
Frequently Asked Questions
What is the ICD-10 code for ruvalcaba-myhre-smith syndrome?
The ICD-10-CM code for ruvalcaba-myhre-smith syndrome is E71.440. The full clinical description is "Ruvalcaba-Myhre-Smith syndrome". E71.440 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code E71.440 mean?
ICD-10-CM code E71.440 represents “Ruvalcaba-Myhre-Smith syndrome”. It is classified under Chapter 4: Endocrine, Nutritional and Metabolic Diseases and is a billable/specific code that can be used on a claim.
Is E71.440 a billable code?
Yes, E71.440 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is E71.440 in?
E71.440 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).
What codes cannot be used with E71.440?
E71.440 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); and 4 more.
What SNOMED CT codes does E71.440 map to?
E71.440 maps to 2 SNOMED CT concepts: 234138005, 722859001. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for E71.440?
E71.440 is linked to 1 UMLS Concept Unique Identifier: C0265326. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does E71.440 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like ruvalcaba-myhre-smith syndrome affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of E71.440?
There is no direct ICD-11 mapping available for E71.440 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.